StonvexLoading…
StonvexStonvexStonvexCore line items from CHCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $348.00K | $1.22M | $906.00K | $602.00K |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $1.59M | $-3.18M | $-5.01M | $-6.76M |
EPS (Diluted) | $0.03 | $-0.23 | $-0.27 | $-0.31 |
Total Assets | $985.11M | $992.56M | $981.78M | $983.20M |
Total Liabilities | $523.79M | $516.60M | $504.63M | $485.43M |
Cash & Equivalents | $2.27M | $4.38M | $2.84M | $734.00K |
Free Cash Flow OCF − CapEx | $9.73M | $34.24M | $23.73M | $17.07M |
Shares Outstanding | 28.34M | 28.24M | 28.24M | 28.05M |